Pay in 4 interest-free payments of $5.85 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
PubMed laboratory research record [PMID: 38426245] PubMed record related to this compound for laboratory literature review
Active, not recruiting NASH Cirrhosis, Liver Drug: Resmetirom Drug: Placebo A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide (AMAZE 7) The purpose of this study is to find out if zenagamtide is safe and effective for treating participants who have excess body weight compared to treat
Excretion occurs primarily through the urine and feces as inactive metabolites, and steady-state concentrations are achieved after four to five weeks of weekly dosing, consistent with its extended half-life[10]
Farrokhi F, Klindukhova O, Chandra P, Peng L, Smiley D, Newton C, et al
US$ 25.74
US$ 21.86
US$ 21.98
US$ 22.34
US$ 24.75
US$ 26.25
